HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David J Webb Selected Research

1- palmitoyl- 2- arachidonyl- 3- phosphorylcholine

7/2007Toll-like receptor 4 signalling is neither sufficient nor required for oxidised phospholipid mediated induction of interleukin-8 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David J Webb Research Topics

Disease

41Hypertension (High Blood Pressure)
01/2022 - 09/2002
25Chronic Renal Insufficiency
10/2021 - 04/2006
16Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 05/2002
9Proteinuria
01/2019 - 07/2009
8Heart Failure
04/2021 - 06/2003
7Pulmonary Arterial Hypertension
01/2019 - 08/2008
7Atherosclerosis
05/2015 - 01/2007
6Type 2 Diabetes Mellitus (MODY)
01/2020 - 09/2006
6Fibrosis (Cirrhosis)
02/2017 - 02/2004
6Inflammation (Inflammations)
12/2016 - 04/2004
6Pulmonary Hypertension
03/2013 - 08/2002
5Acute Kidney Injury (Acute Renal Failure)
04/2021 - 02/2013
5Kidney Diseases (Kidney Disease)
01/2021 - 09/2009
5Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 11/2007
5Poisoning
05/2019 - 09/2011
5Necrosis
10/2017 - 03/2007
5Epilepsy (Aura)
01/2016 - 02/2005
5Essential Hypertension
08/2015 - 08/2002
5Coronary Artery Disease (Coronary Atherosclerosis)
08/2007 - 08/2002
4Atherosclerotic Plaque (Atheroma)
01/2011 - 04/2004
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019 - 11/2006
3Portal Hypertension
10/2012 - 02/2004
3Vascular System Injuries
07/2012 - 03/2003
3Erectile Dysfunction
03/2008 - 09/2002
2Pancreatitis
04/2021 - 04/2021
2Infections
04/2021 - 04/2004
2Pancreatic Neoplasms (Pancreatic Cancer)
04/2021 - 02/2012
2Vasculitis (Vasculitides)
01/2021 - 01/2019
2Drug-Related Side Effects and Adverse Reactions
05/2019 - 12/2007
2Stroke (Strokes)
01/2018 - 01/2014
2Diabetes Mellitus
01/2018 - 08/2015
2Neoplasms (Cancer)
01/2018 - 02/2012
2Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
11/2016 - 12/2013
2Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2016 - 10/2013
2Disease Progression
03/2015 - 05/2002
2Anaphylaxis (Anaphylactic Shock)
02/2014 - 04/2013
2Vomiting
02/2014 - 04/2013
2Altitude Sickness (Mountain Sickness)
01/2011 - 05/2007
2Thrombosis (Thrombus)
05/2008 - 12/2005

Drug/Important Bio-Agent (IBA)

24Endothelins (Endothelin)IBA
01/2021 - 08/2002
19Endothelin-1 (Endothelin 1)IBA
12/2021 - 08/2002
14Endothelin Receptor AntagonistsIBA
01/2021 - 08/2002
9SodiumIBA
12/2021 - 12/2006
9Biomarkers (Surrogate Marker)IBA
01/2017 - 02/2004
9Endothelin A ReceptorIBA
03/2015 - 08/2002
8Acetaminophen (Paracetamol)FDA LinkGeneric
01/2022 - 09/2011
8Sildenafil Citrate (Viagra)FDA Link
08/2015 - 10/2004
7Endothelin Receptors (Endothelin Receptor)IBA
01/2019 - 06/2003
6Pharmaceutical PreparationsIBA
01/2021 - 08/2015
6DiureticsIBA
09/2017 - 08/2015
6Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2013 - 05/2002
5Antihypertensive Agents (Antihypertensives)IBA
01/2020 - 08/2007
5LipidsIBA
01/2019 - 04/2004
5Bosentan (Tracleer)FDA Link
04/2016 - 06/2006
5CreatinineIBA
08/2015 - 06/2009
5Uric Acid (Urate)IBA
05/2014 - 11/2006
5Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2014 - 09/2002
5Phosphodiesterase 5 InhibitorsIBA
03/2013 - 10/2004
4SaltsIBA
12/2021 - 12/2006
4Spironolactone (Aldactone)FDA LinkGeneric
10/2021 - 11/2015
4Endothelin B ReceptorIBA
01/2019 - 08/2006
4Vasoconstrictor AgentsIBA
02/2017 - 08/2002
4C-Reactive ProteinIBA
12/2016 - 06/2009
4Angiotensin Receptor AntagonistsIBA
04/2016 - 02/2004
4Nifedipine (Adalat)FDA LinkGeneric
03/2015 - 07/2009
3AtrasentanIBA
12/2021 - 09/2017
3Chlorthalidone (Chlortalidone)FDA LinkGeneric
10/2021 - 05/2013
3Peptides (Polypeptides)IBA
01/2021 - 05/2010
3AntiemeticsIBA
05/2019 - 04/2013
3Interleukin-6 (Interleukin 6)IBA
12/2016 - 05/2013
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2016 - 06/2004
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2016 - 02/2005
3Gabapentin (Neurontin)FDA LinkGeneric
02/2012 - 07/2009
3Losartan (Cozaar)FDA LinkGeneric
01/2012 - 02/2004
3sitaxsentanIBA
04/2011 - 11/2007
3cyclo(Trp-Asp-Pro-Val-Leu)IBA
07/2009 - 08/2002
3BradykininIBA
01/2008 - 06/2004
2Glucose (Dextrose)FDA LinkGeneric
04/2021 - 08/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 04/2004
2Streptozocin (Streptozotocin)FDA Link
01/2019 - 05/2014
2Amiloride (Midamor)FDA LinkGeneric
01/2018 - 02/2016
2AldosteroneIBA
01/2018 - 04/2016
2Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2018 - 04/2016
2ReninIBA
01/2018 - 08/2015
2Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
11/2016 - 12/2013
2ambrisentanFDA Link
04/2016 - 12/2008
2CholesterolIBA
02/2015 - 03/2007
2Acetylcysteine (Siran)FDA LinkGeneric
02/2014 - 02/2012
2Ondansetron (Zofran)FDA LinkGeneric
02/2014 - 04/2013
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2014 - 12/2005
2HomocysteineIBA
01/2014 - 01/2005
2Plasminogen InactivatorsIBA
01/2014 - 01/2008
2AlbuminsIBA
10/2012 - 06/2009
2Proteins (Proteins, Gene)FDA Link
10/2012 - 04/2011
2Angiotensin IIIBA
01/2012 - 02/2004
2Apolipoproteins E (ApoE)IBA
02/2011 - 01/2011
2Phospholipids (Phosphatides)FDA LinkGeneric
09/2008 - 07/2007
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2008 - 05/2007

Therapy/Procedure

17Therapeutics
01/2022 - 07/2002
2Ligation
12/2021 - 02/2011